化工儀器網
技術文章
測量應用案例-2016-62
閱讀：187 發布時間：2016-10-20Self-assembled IR780-loaded transferrin nanoparticles as an imaging, targeting and PDT/PTT agent for cancer therapy
作者： Kaikai Wang1,2, Yifan Zhang1, Juan Wang1, Ahu Yuan1, Minjie Sun2, Jinhui Wu1,2,3,4 &Yiqiao Hu1,3,4
1State Key Laboratory of Pharmaceutical Biotechnology, Medical School of Nanjing University, Nanjing 210093,China.
2State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
3Institute of Drug R&D, Medical School of Nanjing University, Nanjing 210093, China.
4Jiangsu R&D Platform for Controlled & Targeted Drug Delivery, Nanjing University, Nanjing 210093, China.
摘要：Combination of photothermal and photodynamic therapy (PTT/PDT) offer unique advantages over PDT alone. However, to achieve synergetic PDT/PTT effect, one generally needs two lasers with different wavelengths. Near-infrared dye IR-780 could be used as photosensitizer both for PTT and PDT, but its lipophilicity limits its practical use and in vivo efficiency. Herein, a simple multifunctional IR780-loaded nanoplatform based on transferrin was developed for targeted imaging and phototherapy of cancer compatible with a single-NIR-laser irradiation. The self-assembled transferrin-IR780 nanoparticles (Tf-IR780 NPs) exhibited narrow size distribution, good photo-stability, and encouraging photothermal performance with enhanced generation of ROS under laser irradiation. Following intravenous injection, Tf-IR780 NPs had a high tumor-to-background ratio in CT26 tumor-bearing mice. Treatment with Tf-IR780 NPs resulted in significant tumor suppression. Overall, the Tf-IR780 NPs show notable targeting and theranostic potential in cancer therapy.